Mouse models of GBA1 Parkinson’s disease that are treated with Gain Therapeutics’ clinical-stage drug appear to have better cognitive function and lower disease biomarkers than untreated animals. The ...
Patient-centric trial aiming to evaluate whether bezisterim can help delay disease progression reaches enrollment milestone -- Topline Results ...
Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s disease and Parkinson’s in a new collaboration which aims to discover ...
Symptoms of Parkinson’s disease, such as tremors and stiffness, can make daily tasks difficult. A new drug has shown promise in alleviating symptoms. Tavapadon, a drug being tested to treat early ...
Clinical Trials Arena on MSN
NRG doses first participants in Phase I trial for ALS and Parkinson’s
NRG Therapeutics has dosed the first participants in its Phase I clinical trial of NRG5051, being developed as a ...
An experimental Parkinson’s disease drug on its way to AbbVie as part of an $8.7 billion acquisition has met the goals of a pivotal study, setting up the pharmaceutical giant with a drug prospect that ...
CINCINNATI (WKRC) - A new wearable drug delivery device made by Enable Injections in Evendale could soon help change the lives of those living with a progressive disorder that impacts the nervous ...
Gain Therapeutics’ phase 1 drug for Parkinson’s disease associated with a common gene mutation appears to restore motor function in mice, even after a delay between symptom onset and treatment, new ...
How well our brain functions depends heavily on the performance of our nerve cells. That is why they are regularly checked for their proper function -- defective cell components are marked, disposed ...
Hosted on MSN
Pseudoparkinsonism Symptoms and Their Treatment
Pseudoparkinsonism (parkinsonism) refers to symptoms like tremors and gait (walking) problems that occur as medication side effects. The symptoms go away when the drug is discontinued. Parkinsonism ...
Jan. 14 -- WEDNESDAY, Jan. 13 (HealthDay News) -- Reduced dosages of dopamine agonists, drugs routinely used to treat Parkinson's disease, can cause symptoms similar to those experienced by addicts in ...
Taking antiepileptic drugs (AEDs) was associated with a subsequent diagnosis of Parkinson's disease (PD), a U.K.-based case control study suggested. There was a significant association between AED ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results